MillensonMM. Demanding medical excellence: doctors and accountability in the information age. Chicago: The University of Chicago Press, 1997;423.
2.
ZapolWM, SniderMT, HillJD, FallatRJ, BartlettRH, EdmundsLH, et al. Extracorporeal membrane oxygenation in severe acute respiratory failure. A randomized prospective study. JAMA1979;242(20):2193–2196.
3.
MorrisAH, WallaceCJ, MenloveRL, ClemmerTP, OrmeJFJr., WeaverLK, et al. Randomized clinical trial of pressure-controlled inverse ratio ventilation and extracorporeal CO₂ removal for adult respiratory distress syndrome. Am J Respir Crit Care Med1994;149(2 Pt 1):295–305.
4.
BernardGR, LuceJM, SprungCL, RinaldoJE, TateRM, SibbaldWJ, et al. High-dose corticosteroids in patients with the adult respiratory distress syndrome. N Engl J Med1987;317(25):1565–1570.
5.
FuhrmanBP. Partial liquid ventilation and the challenges of randomized, controlled trials in ARDS. Respir Care1998;43(12):(in press).
6.
WennbergDE, LucasFL, BirkmeyerJD, BredenbergCE, FisherES. Variation in carotid endarterectomy mortality in the Medicare population: trial hospitals, volume, and patient characteristics. JAMA1998;279(16):1278–1281.
7.
GardnerRM, ShabotMM. Computerized ICU data management: pitfalls and promises (review). Int J Clin Monit Comput1990;7(2):99–105.
8.
EvansS, LemonSJ, DetersC, FusaroRM, DurhamC, SnyderC, LynchHT. Using data mining to characterize DNA mutations by patient clinical features. Proc AMIA Annu Fall Symp1997;253–257.
9.
EvansS, LemonSJ, DetersCA, FusaroRM, LynchHT. Automated detection of hereditary syndromes using data mining. Comput Biomed Res1997;30(5):337–348.
10.
PratherJC, LobachDF, GoodwinLK, HalesJW, HageML, HammondWE. Medical data mining: knowledge discovery in a clinical data warehouse. Proc AMIA Annu Fall Symp1997;101–105.
11.
MilbergJA, DavisDR, SteinbergKP, HudsonLD. Improved survival of patients with acute respiratory distress syndrome (ARDS): 1983-1993. JAMA1995;273(4):306–309.
12.
FacklerJ, BohnD, GreenT, HeulittM, HirshlR, KleinM, et al. ECMO for ARDS: Stopping a RCT (abstract). Am J Respir Crit Care Med1997;155(4 Pt 2):A504.
13.
TimmonsOD, HavensPL, FacklerJC. Predicting death in pediatric patients with acute respiratory failure. Chest1995;108:789–797.
14.
TeasdaleGM, NicollJAR, MurrayG, FiddesM.Association of apolipoprotein E polymorphism with outcome after head injury. Lancet1997;350:1069–1071.
15.
NewmanMF, CroughwellND, BlumenthalJA, LowryE, WhiteWD, SpillaneW, et al. Predictors of cognitive decline after cardiac operation. Ann Thorac Surg1995;59(5):1326–1330.
16.
MunozFM, HawkinsEP, BullardDC, BeaudetAL, KaplanSL. Host defense against systemic infection with Streptococcus pneumoniae is impaired in E-, P-, and E-/P-selectin-deficient mice. J Clin Invest1997;100(8):2099–2106.
17.
YamasakiK, EdingtonHD, McCloskyC, TeengE, LizonovaA, KovesdiI, et al. Reversal of impaired wound repair in iNOS-deficient mice by topical adenoviral-mediated iNOS gene transfer. J Clin Invest1998;101(5):967–971.
18.
MeduriGU, HeadleyAS, GoldenE, CarsonSJ, UmbergerRA, KelsoT, TolleyEA. Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial. JAMA1998;280(2):159–165.
19.
MassaroGD, MassaroD.Postnatal treatment with retinoic acid increases the number of pulmonary alveoli in rats. Am J Physiol1996;270(2 Pt 1):L305–L310.
20.
SinghJP, BoninPD. Inhibition of proliferation of fibroblasts by lazaroids (21-aminosteroids). Life Sci1991;49(26):2053–2058.
21.
JohnsonD, HurstT, PrasadK, WilsonT, SaxenaA, MurphyF, MayersI.Lazaroid pretreatment preserves gas exchange in endotoxin-treated dogs. J Crit Care1994;9(4):213–222.
22.
MiniatiM, CocciF, MontiS, FiuppiE, SarnelliR, FerdeghiniM, et al. Lazaroid U-74389F attenuates phorbol ester-induced lung injury in rabbits. Eur Respir J1996;9(4):758–764.
23.
NakayamaM, HasegawaN, OkaY, LutzkeB, McCallJM, RaffinTA. Effects of the lazaroid, tirilazad mesylate, on sepsis-induced acute lung injury in minipigs. Crit Care Med1998;26(3):538–547.
24.
ChytilF.Retinoids in lung development (review). FASEB J1996;10(9):986–992.
ZitnikRJ, KotloffRM, LatifpourJ, ZhengT, WhitingNL, SchwalbJ, EliasJL. Retinoic acid inhibition of IL-1-induced IL-6 production by human lung fibroblasts. J Immunol1994;152(3):1419–1427.
27.
KrnjevicK.Anoxia and NMDA receptors. In: Ben-AriY, editor. Excitatory amino acids and neuronal plasticity. New York: Plenum Press, 1990;475–479.
28.
UematsuD, GreenbergJH, ArakiN, ReivichM.Mechanism underlying protective effect of MK-801 against NMDA-induced neuronal injury in vivo. J Cereb Blood Flow Metab1991;11(5):779–785.
29.
SheardownMJ, NielsenEO, HansenAJ, JacobsenP, HonoreT.2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline: a neuroprotectant for cerebral ischemia. Science1990;247(4942):571–574.
30.
SaidSI, BerishaHI, PakbazH.N-methyl-D-aspartate receptors outside the central nervous system: activation causes acute lung injury that is mediated by nitric oxide synthesis and prevented by vasoactive intestinal peptide. Neuroscience1995;65(4):943–946.
31.
SaidSI, BerishaHI, PakbazH.Excitotoxicity in the lung: N-methyl-D-aspartate-induced, nitric oxide-dependent, pulmonary edema is attenuated by vasoactive intestinal peptide and by inhibitors of poly-(ADP-ribose) polymerase. Proc Natl Acad Sci USA1996;93(10):4688–4692.
32.
SaidSI. Molecules that protect: the defense of neurons and other cells (editorial). J Clin Invest1996;97(10):2163–2164.
